Rank | Gene Set | Z-score |
---|---|---|
1 | short-term memory (GO:0007614) | 9.02773210 |
2 | presynaptic membrane assembly (GO:0097105) | 5.49237093 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.07624280 |
4 | postsynaptic membrane organization (GO:0001941) | 5.05954985 |
5 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 4.87973983 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.86185850 |
7 | regulation of pigment cell differentiation (GO:0050932) | 4.82774813 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.68486911 |
9 | negative regulation of cell killing (GO:0031342) | 4.68486911 |
10 | presynaptic membrane organization (GO:0097090) | 4.59325250 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.54634159 |
12 | modulation by symbiont of host immune response (GO:0052553) | 4.54634159 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.54634159 |
14 | modulation by symbiont of host defense response (GO:0052031) | 4.54634159 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.54634159 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.54634159 |
17 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.40996666 |
18 | neutrophil activation involved in immune response (GO:0002283) | 4.37467611 |
19 | detection of other organism (GO:0098543) | 4.19822095 |
20 | positive regulation of protein kinase C signaling (GO:0090037) | 4.18639841 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15631618 |
22 | central nervous system myelination (GO:0022010) | 4.15192880 |
23 | axon ensheathment in central nervous system (GO:0032291) | 4.15192880 |
24 | regulation of protein kinase C signaling (GO:0090036) | 4.14237506 |
25 | neuronal action potential propagation (GO:0019227) | 4.14133384 |
26 | response to folic acid (GO:0051593) | 4.11684182 |
27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02808420 |
28 | positive regulation of dendritic spine development (GO:0060999) | 4.02623867 |
29 | cellular extravasation (GO:0045123) | 3.99863015 |
30 | lymph vessel development (GO:0001945) | 3.97753695 |
31 | macrophage activation involved in immune response (GO:0002281) | 3.91959673 |
32 | negative regulation of interleukin-12 production (GO:0032695) | 3.89288433 |
33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.88865518 |
34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.88371160 |
35 | response to peptidoglycan (GO:0032494) | 3.82179927 |
36 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.79019297 |
37 | detection of bacterium (GO:0016045) | 3.77355303 |
38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76186077 |
39 | metanephric nephron tubule development (GO:0072234) | 3.75988378 |
40 | metanephric tubule development (GO:0072170) | 3.75988378 |
41 | pattern specification involved in kidney development (GO:0061004) | 3.75000569 |
42 | angiogenesis involved in wound healing (GO:0060055) | 3.74445989 |
43 | detection of molecule of bacterial origin (GO:0032490) | 3.73252944 |
44 | negative regulation of myotube differentiation (GO:0010832) | 3.72783182 |
45 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.70257639 |
46 | positive regulation of synapse assembly (GO:0051965) | 3.69201843 |
47 | macrophage activation (GO:0042116) | 3.65102308 |
48 | facial nerve structural organization (GO:0021612) | 3.63034173 |
49 | metanephric nephron epithelium development (GO:0072243) | 3.62338982 |
50 | detection of external biotic stimulus (GO:0098581) | 3.62226133 |
51 | amino sugar catabolic process (GO:0046348) | 3.59303943 |
52 | DNA ligation (GO:0006266) | 3.57407628 |
53 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.55473760 |
54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52919945 |
55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47324106 |
56 | endothelial tube morphogenesis (GO:0061154) | 3.46616594 |
57 | morphogenesis of an endothelium (GO:0003159) | 3.46616594 |
58 | omega-hydroxylase P450 pathway (GO:0097267) | 3.45962940 |
59 | metanephric epithelium development (GO:0072207) | 3.41363175 |
60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34747271 |
61 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.33596444 |
62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.32055784 |
63 | neutrophil activation (GO:0042119) | 3.31221697 |
64 | microglial cell activation (GO:0001774) | 3.30181816 |
65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.29232935 |
66 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.28016404 |
67 | developmental pigmentation (GO:0048066) | 3.27069670 |
68 | cranial nerve morphogenesis (GO:0021602) | 3.26272250 |
69 | viral transcription (GO:0019083) | 3.26206089 |
70 | immunoglobulin mediated immune response (GO:0016064) | 3.23466813 |
71 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.21390744 |
72 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.21059338 |
73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18278949 |
74 | response to host immune response (GO:0052572) | 3.18033937 |
75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18033937 |
76 | detection of biotic stimulus (GO:0009595) | 3.17810276 |
77 | glucosamine-containing compound catabolic process (GO:1901072) | 3.17427306 |
78 | negative regulation of Ras GTPase activity (GO:0034261) | 3.17418943 |
79 | neuron remodeling (GO:0016322) | 3.17357716 |
80 | limb bud formation (GO:0060174) | 3.16259991 |
81 | lymphangiogenesis (GO:0001946) | 3.14212478 |
82 | translational termination (GO:0006415) | 3.13756382 |
83 | regulation of tolerance induction (GO:0002643) | 3.13423982 |
84 | cranial nerve structural organization (GO:0021604) | 3.13261821 |
85 | regulation of mast cell degranulation (GO:0043304) | 3.12975459 |
86 | regulation of T cell tolerance induction (GO:0002664) | 3.12859704 |
87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11843747 |
88 | eyelid development in camera-type eye (GO:0061029) | 3.11656214 |
89 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.10860229 |
90 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.08944204 |
91 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.08052976 |
92 | positive regulation of amino acid transport (GO:0051957) | 3.07716654 |
93 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 3.06651796 |
94 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.04326907 |
95 | granulocyte activation (GO:0036230) | 3.03644657 |
96 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03615119 |
97 | myeloid cell activation involved in immune response (GO:0002275) | 3.03045589 |
98 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.01552300 |
99 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.99827046 |
100 | positive regulation of tolerance induction (GO:0002645) | 2.98064991 |
101 | blood vessel maturation (GO:0001955) | 2.96780992 |
102 | vocalization behavior (GO:0071625) | 2.96305408 |
103 | response to muramyl dipeptide (GO:0032495) | 2.96192003 |
104 | positive regulation of mast cell activation (GO:0033005) | 2.96053871 |
105 | positive regulation of B cell differentiation (GO:0045579) | 2.95195700 |
106 | protein heterotetramerization (GO:0051290) | 2.94123953 |
107 | response to host (GO:0075136) | 2.93281078 |
108 | response to host defenses (GO:0052200) | 2.93281078 |
109 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93281078 |
110 | positive regulation of protein autophosphorylation (GO:0031954) | 2.91891950 |
111 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91766456 |
112 | organ growth (GO:0035265) | 2.91720792 |
113 | membrane assembly (GO:0071709) | 2.90240601 |
114 | ribosomal small subunit biogenesis (GO:0042274) | 2.89508383 |
115 | positive thymic T cell selection (GO:0045059) | 2.88421281 |
116 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88187389 |
117 | regulation of dendritic spine development (GO:0060998) | 2.88078502 |
118 | regulation of leukocyte degranulation (GO:0043300) | 2.85989024 |
119 | cotranslational protein targeting to membrane (GO:0006613) | 2.85342841 |
120 | germinal center formation (GO:0002467) | 2.85288100 |
121 | regulation of mast cell activation (GO:0033003) | 2.85176328 |
122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84474179 |
123 | B cell receptor signaling pathway (GO:0050853) | 2.84052369 |
124 | GTP biosynthetic process (GO:0006183) | 2.83935797 |
125 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.83796608 |
126 | GMP metabolic process (GO:0046037) | 2.83133367 |
127 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82784767 |
128 | neuron cell-cell adhesion (GO:0007158) | 2.81824657 |
129 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81731599 |
130 | protein targeting to ER (GO:0045047) | 2.81329389 |
131 | response to interleukin-15 (GO:0070672) | 2.79648088 |
132 | respiratory burst (GO:0045730) | 2.77451187 |
133 | neutrophil mediated immunity (GO:0002446) | 2.77274142 |
134 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77240630 |
135 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.77143775 |
136 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.76045423 |
137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75458662 |
138 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.75432279 |
139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.75135013 |
140 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.74353944 |
141 | leukocyte aggregation (GO:0070486) | 2.73392863 |
142 | positive regulation of vasculogenesis (GO:2001214) | 2.73198664 |
143 | regulation of synapse assembly (GO:0051963) | 2.72518339 |
144 | mesonephros development (GO:0001823) | 2.72141576 |
145 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.71411309 |
146 | positive regulation of metanephros development (GO:0072216) | 2.70670037 |
147 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.70333186 |
148 | myeloid leukocyte activation (GO:0002274) | 2.70188798 |
149 | regulation of antigen processing and presentation (GO:0002577) | 2.69768882 |
150 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68820229 |
151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66795430 |
152 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66795430 |
153 | import into cell (GO:0098657) | 2.65507397 |
154 | branch elongation of an epithelium (GO:0060602) | 2.64825389 |
155 | regulation of macrophage cytokine production (GO:0010935) | 2.63982987 |
156 | ventricular system development (GO:0021591) | 2.63642233 |
157 | righting reflex (GO:0060013) | 2.62936091 |
158 | epithelial cilium movement (GO:0003351) | 2.62756837 |
159 | Rap protein signal transduction (GO:0032486) | 2.62247062 |
160 | embryonic body morphogenesis (GO:0010172) | 2.61902109 |
161 | sprouting angiogenesis (GO:0002040) | 2.61306910 |
162 | glomerular basement membrane development (GO:0032836) | 2.59624184 |
163 | * endothelium development (GO:0003158) | 2.59017352 |
164 | lateral sprouting from an epithelium (GO:0060601) | 2.58779264 |
165 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.58597796 |
166 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.58566101 |
167 | positive regulation of mast cell degranulation (GO:0043306) | 2.58528353 |
168 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.58528353 |
169 | positive regulation of receptor recycling (GO:0001921) | 2.57009138 |
170 | regulation of axon guidance (GO:1902667) | 2.56555542 |
171 | protein localization to endoplasmic reticulum (GO:0070972) | 2.56522851 |
172 | centriole replication (GO:0007099) | 2.56237966 |
173 | regulation of B cell differentiation (GO:0045577) | 2.55907034 |
174 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.54409583 |
175 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54012568 |
176 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.53360748 |
177 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.52905821 |
178 | regulation of protein kinase A signaling (GO:0010738) | 2.52863858 |
179 | amino acid import (GO:0043090) | 2.50477274 |
180 | positive regulation of odontogenesis (GO:0042482) | 2.49674224 |
181 | cellular response to interleukin-15 (GO:0071350) | 2.48653892 |
182 | leukocyte degranulation (GO:0043299) | 2.48268681 |
183 | sphingoid metabolic process (GO:0046519) | 2.47389860 |
184 | T-helper 1 type immune response (GO:0042088) | 2.46929088 |
185 | cilium movement (GO:0003341) | 2.46548220 |
186 | neutrophil chemotaxis (GO:0030593) | 2.46296721 |
187 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.45777298 |
188 | response to hyperoxia (GO:0055093) | 2.45672352 |
189 | response to increased oxygen levels (GO:0036296) | 2.45672352 |
190 | * nephron epithelium development (GO:0072009) | 2.45131842 |
191 | forebrain neuron development (GO:0021884) | 2.44881736 |
192 | positive regulation of type 2 immune response (GO:0002830) | 2.44867354 |
193 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44811368 |
194 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.44779820 |
195 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.44683649 |
196 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.43004068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.06563928 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60010294 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.62509653 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.41644295 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.39348964 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34269098 |
7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.31472810 |
8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.20226873 |
9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.16087282 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15261635 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02204674 |
12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99418457 |
13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.97835790 |
14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.85177981 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.67072771 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61908499 |
17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59162026 |
18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58991548 |
19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58892512 |
20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.54209804 |
21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50528577 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.47464776 |
23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.46742230 |
24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43735918 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39259855 |
26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39259855 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39189708 |
28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31944453 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.31163350 |
30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30923293 |
31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30386407 |
32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.26422698 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25316114 |
34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24938529 |
35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24273486 |
36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18546860 |
37 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.15714229 |
38 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.15714229 |
39 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.15714229 |
40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10732477 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.10414206 |
42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.10359918 |
43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.09083718 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05981497 |
45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.01850121 |
46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98152019 |
47 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96696671 |
48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95814388 |
49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.95673897 |
50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93656368 |
51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.92596632 |
52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92480628 |
53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90393431 |
54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89032587 |
55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87498971 |
56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85904311 |
57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85381193 |
58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84713627 |
59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83482201 |
60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82506673 |
61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.81266008 |
62 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79431012 |
63 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79355773 |
64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75147080 |
65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75116974 |
66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74594382 |
67 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.74344575 |
68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73553044 |
69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.73507947 |
70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73060104 |
71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72577150 |
72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71536727 |
73 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70499030 |
74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70313998 |
75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70114242 |
76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69066128 |
77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68018617 |
78 | MYB_26560356_Chip-Seq_TH2_Human | 1.65200501 |
79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.64747700 |
80 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64488108 |
81 | MAF_26560356_Chip-Seq_TH1_Human | 1.63434329 |
82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62085133 |
83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58304039 |
84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57276842 |
85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.55670974 |
86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54860308 |
87 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54683059 |
88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53378558 |
89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53046482 |
90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52388455 |
91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.50675749 |
92 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49309129 |
93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47379646 |
94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47215816 |
95 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46571239 |
96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45717498 |
97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45429281 |
98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.45263283 |
99 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45095610 |
100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42192482 |
101 | MYB_26560356_Chip-Seq_TH1_Human | 1.40993049 |
102 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38303971 |
103 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37480561 |
104 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37443816 |
105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36624918 |
106 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.36152834 |
107 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34992242 |
108 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34779653 |
109 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34687258 |
110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33251345 |
111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32438030 |
112 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32225158 |
113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32069170 |
114 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31961876 |
115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29775243 |
116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29616630 |
117 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28195265 |
118 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28025647 |
119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27831110 |
120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26148533 |
121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25198938 |
122 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25193469 |
123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24700805 |
124 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24406658 |
125 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24177571 |
126 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.23811139 |
127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23807758 |
128 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23671916 |
129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22003707 |
130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20407688 |
131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20344955 |
132 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17104839 |
133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17009830 |
134 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14942362 |
135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13647056 |
136 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13614540 |
137 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13234041 |
138 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12916635 |
139 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12406917 |
140 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12254309 |
141 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.12119389 |
142 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09050778 |
143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07844539 |
144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06423754 |
145 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06244404 |
146 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05982461 |
147 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05814386 |
148 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04061704 |
149 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03771795 |
150 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03568063 |
151 | MAF_26560356_Chip-Seq_TH2_Human | 1.02950293 |
152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02242213 |
153 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02181322 |
154 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01260304 |
155 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00242971 |
156 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99678322 |
157 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99521987 |
158 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99501107 |
159 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99432116 |
160 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98457261 |
161 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98149638 |
162 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98011411 |
163 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97555048 |
164 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97397619 |
165 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95915504 |
166 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95138449 |
167 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95014167 |
168 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94997460 |
169 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94835796 |
170 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94531492 |
171 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94531492 |
172 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94085659 |
173 | MYC_22102868_ChIP-Seq_BL_Human | 0.93867840 |
174 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92919627 |
175 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92861984 |
176 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92430766 |
177 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91888343 |
178 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91769701 |
179 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.91136492 |
180 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89540719 |
181 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87550667 |
182 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85987621 |
183 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85402421 |
184 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78892150 |
185 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74945408 |
186 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74492220 |
187 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74174698 |
188 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73246278 |
189 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72913211 |
190 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72872261 |
191 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72562924 |
192 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72389386 |
193 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72228213 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009379_abnormal_foot_pigmentation | 8.80748517 |
2 | MP0005409_darkened_coat_color | 5.30538797 |
3 | MP0001188_hyperpigmentation | 5.05237053 |
4 | MP0003136_yellow_coat_color | 4.73262166 |
5 | MP0003880_abnormal_central_pattern | 3.27608084 |
6 | MP0003436_decreased_susceptibility_to | 3.08054234 |
7 | * MP0003303_peritoneal_inflammation | 3.07358471 |
8 | MP0001835_abnormal_antigen_presentation | 2.89534173 |
9 | MP0010368_abnormal_lymphatic_system | 2.78696800 |
10 | MP0004272_abnormal_basement_membrane | 2.76143749 |
11 | MP0001879_abnormal_lymphatic_vessel | 2.74623400 |
12 | MP0002419_abnormal_innate_immunity | 2.59609257 |
13 | MP0002102_abnormal_ear_morphology | 2.54826365 |
14 | MP0004381_abnormal_hair_follicle | 2.51117052 |
15 | MP0003300_gastrointestinal_ulcer | 2.48794825 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.43052341 |
17 | MP0006082_CNS_inflammation | 2.28840593 |
18 | MP0000015_abnormal_ear_pigmentation | 2.28543753 |
19 | MP0005025_abnormal_response_to | 2.26479276 |
20 | MP0005174_abnormal_tail_pigmentation | 2.24099323 |
21 | MP0005464_abnormal_platelet_physiology | 2.23522211 |
22 | MP0005671_abnormal_response_to | 2.20677922 |
23 | MP0009785_altered_susceptibility_to | 2.20474419 |
24 | MP0005387_immune_system_phenotype | 2.16002976 |
25 | MP0001790_abnormal_immune_system | 2.16002976 |
26 | MP0002138_abnormal_hepatobiliary_system | 2.14629158 |
27 | * MP0005000_abnormal_immune_tolerance | 2.13212048 |
28 | MP0001800_abnormal_humoral_immune | 2.09758712 |
29 | MP0000685_abnormal_immune_system | 2.06955964 |
30 | MP0002452_abnormal_antigen_presenting | 1.96960225 |
31 | MP0006292_abnormal_olfactory_placode | 1.93510896 |
32 | * MP0002420_abnormal_adaptive_immunity | 1.93216086 |
33 | MP0001986_abnormal_taste_sensitivity | 1.92546640 |
34 | MP0002148_abnormal_hypersensitivity_rea | 1.91507398 |
35 | * MP0001819_abnormal_immune_cell | 1.91468630 |
36 | * MP0002723_abnormal_immune_serum | 1.91081723 |
37 | * MP0003724_increased_susceptibility_to | 1.82136090 |
38 | * MP0001533_abnormal_skeleton_physiology | 1.78105067 |
39 | MP0005058_abnormal_lysosome_morphology | 1.77036938 |
40 | MP0003172_abnormal_lysosome_physiology | 1.75031791 |
41 | MP0010155_abnormal_intestine_physiology | 1.67688676 |
42 | MP0003941_abnormal_skin_development | 1.67261013 |
43 | MP0002405_respiratory_system_inflammati | 1.66416385 |
44 | MP0009764_decreased_sensitivity_to | 1.63620963 |
45 | MP0002177_abnormal_outer_ear | 1.54477640 |
46 | MP0000343_altered_response_to | 1.52977635 |
47 | MP0003279_aneurysm | 1.50640663 |
48 | MP0003075_altered_response_to | 1.50039438 |
49 | MP0009278_abnormal_bone_marrow | 1.49421384 |
50 | MP0000049_abnormal_middle_ear | 1.47724838 |
51 | MP0009250_abnormal_appendicular_skeleto | 1.45791875 |
52 | MP0006054_spinal_hemorrhage | 1.45441251 |
53 | MP0004742_abnormal_vestibular_system | 1.44512411 |
54 | MP0003763_abnormal_thymus_physiology | 1.44394902 |
55 | MP0003938_abnormal_ear_development | 1.43280887 |
56 | * MP0005595_abnormal_vascular_smooth | 1.40859480 |
57 | MP0000716_abnormal_immune_system | 1.39304731 |
58 | MP0002398_abnormal_bone_marrow | 1.36097820 |
59 | MP0004883_abnormal_blood_vessel | 1.34548941 |
60 | * MP0000249_abnormal_blood_vessel | 1.33888339 |
61 | * MP0001845_abnormal_inflammatory_respons | 1.33362404 |
62 | MP0002998_abnormal_bone_remodeling | 1.33141050 |
63 | MP0004510_myositis | 1.32008944 |
64 | MP0003385_abnormal_body_wall | 1.31481200 |
65 | MP0004947_skin_inflammation | 1.31446492 |
66 | MP0006276_abnormal_autonomic_nervous | 1.31351473 |
67 | MP0002249_abnormal_larynx_morphology | 1.26885053 |
68 | MP0004142_abnormal_muscle_tone | 1.26439287 |
69 | MP0002332_abnormal_exercise_endurance | 1.26342452 |
70 | MP0001545_abnormal_hematopoietic_system | 1.25289543 |
71 | MP0005397_hematopoietic_system_phenotyp | 1.25289543 |
72 | MP0005451_abnormal_body_composition | 1.22789914 |
73 | MP0000920_abnormal_myelination | 1.22508329 |
74 | MP0000751_myopathy | 1.21877050 |
75 | MP0003690_abnormal_glial_cell | 1.21459422 |
76 | MP0005166_decreased_susceptibility_to | 1.18651927 |
77 | MP0002095_abnormal_skin_pigmentation | 1.17911154 |
78 | MP0005666_abnormal_adipose_tissue | 1.17552169 |
79 | MP0005165_increased_susceptibility_to | 1.16185426 |
80 | MP0008438_abnormal_cutaneous_collagen | 1.16082109 |
81 | MP0001958_emphysema | 1.15817538 |
82 | MP0001486_abnormal_startle_reflex | 1.14844959 |
83 | MP0002429_abnormal_blood_cell | 1.14524523 |
84 | MP0005171_absent_coat_pigmentation | 1.13612360 |
85 | * MP0000689_abnormal_spleen_morphology | 1.12910161 |
86 | MP0008469_abnormal_protein_level | 1.12899131 |
87 | MP0002722_abnormal_immune_system | 1.12674320 |
88 | MP0003866_abnormal_defecation | 1.11606438 |
89 | MP0002166_altered_tumor_susceptibility | 1.10393042 |
90 | MP0001968_abnormal_touch/_nociception | 1.08402275 |
91 | MP0000858_altered_metastatic_potential | 1.07704151 |
92 | MP0004185_abnormal_adipocyte_glucose | 1.05384713 |
93 | MP0009745_abnormal_behavioral_response | 1.04124831 |
94 | MP0008260_abnormal_autophagy | 1.03901887 |
95 | MP0006138_congestive_heart_failure | 1.03606483 |
96 | MP0000778_abnormal_nervous_system | 1.03426719 |
97 | MP0003868_abnormal_feces_composition | 1.03137863 |
98 | MP0002132_abnormal_respiratory_system | 1.02766280 |
99 | MP0005623_abnormal_meninges_morphology | 1.02547345 |
100 | MP0003448_altered_tumor_morphology | 1.01148276 |
101 | MP0000465_gastrointestinal_hemorrhage | 1.00553310 |
102 | MP0004145_abnormal_muscle_electrophysio | 1.00390418 |
103 | MP0003566_abnormal_cell_adhesion | 0.99030389 |
104 | MP0003937_abnormal_limbs/digits/tail_de | 0.98242024 |
105 | MP0000026_abnormal_inner_ear | 0.97336686 |
106 | MP0005310_abnormal_salivary_gland | 0.94212969 |
107 | MP0002067_abnormal_sensory_capabilities | 0.93495471 |
108 | MP0009333_abnormal_splenocyte_physiolog | 0.92501718 |
109 | MP0003183_abnormal_peptide_metabolism | 0.92233354 |
110 | MP0003635_abnormal_synaptic_transmissio | 0.91719940 |
111 | MP0003045_fibrosis | 0.91005388 |
112 | MP0001915_intracranial_hemorrhage | 0.90957741 |
113 | MP0003646_muscle_fatigue | 0.90494178 |
114 | MP0000613_abnormal_salivary_gland | 0.89919864 |
115 | MP0002272_abnormal_nervous_system | 0.89663796 |
116 | * MP0002933_joint_inflammation | 0.88784533 |
117 | MP0001853_heart_inflammation | 0.88057972 |
118 | MP0001346_abnormal_lacrimal_gland | 0.87971839 |
119 | MP0004130_abnormal_muscle_cell | 0.86782668 |
120 | MP0000631_abnormal_neuroendocrine_gland | 0.86006599 |
121 | MP0005084_abnormal_gallbladder_morpholo | 0.83775904 |
122 | MP0001727_abnormal_embryo_implantation | 0.83198288 |
123 | MP0000762_abnormal_tongue_morphology | 0.82900408 |
124 | MP0000467_abnormal_esophagus_morphology | 0.82297634 |
125 | MP0001919_abnormal_reproductive_system | 0.81420873 |
126 | MP0004808_abnormal_hematopoietic_stem | 0.81381311 |
127 | MP0000372_irregular_coat_pigmentation | 0.80644358 |
128 | MP0000703_abnormal_thymus_morphology | 0.80368429 |
129 | MP0001970_abnormal_pain_threshold | 0.78990068 |
130 | MP0002277_abnormal_respiratory_mucosa | 0.78712362 |
131 | MP0002877_abnormal_melanocyte_morpholog | 0.78034743 |
132 | MP0002064_seizures | 0.77315062 |
133 | MP0002751_abnormal_autonomic_nervous | 0.77242268 |
134 | MP0000604_amyloidosis | 0.77205074 |
135 | * MP0001614_abnormal_blood_vessel | 0.76083918 |
136 | MP0005257_abnormal_intraocular_pressure | 0.76062504 |
137 | MP0000681_abnormal_thyroid_gland | 0.74823874 |
138 | MP0009840_abnormal_foam_cell | 0.74324319 |
139 | MP0003705_abnormal_hypodermis_morpholog | 0.74136730 |
140 | MP0001905_abnormal_dopamine_level | 0.73841893 |
141 | MP0002127_abnormal_cardiovascular_syste | 0.73589275 |
142 | MP0004084_abnormal_cardiac_muscle | 0.72946565 |
143 | MP0009763_increased_sensitivity_to | 0.72827829 |
144 | * MP0005390_skeleton_phenotype | 0.72473173 |
145 | MP0000767_abnormal_smooth_muscle | 0.72035142 |
146 | MP0005423_abnormal_somatic_nervous | 0.71980647 |
147 | MP0003315_abnormal_perineum_morphology | 0.71933594 |
148 | MP0001851_eye_inflammation | 0.71591625 |
149 | MP0009046_muscle_twitch | 0.71559856 |
150 | MP0001542_abnormal_bone_strength | 0.69230238 |
151 | MP0004133_heterotaxia | 0.68970250 |
152 | MP0002752_abnormal_somatic_nervous | 0.68108730 |
153 | MP0001661_extended_life_span | 0.67716794 |
154 | MP0001544_abnormal_cardiovascular_syste | 0.67357932 |
155 | MP0005385_cardiovascular_system_phenoty | 0.67357932 |
156 | MP0000749_muscle_degeneration | 0.67053641 |
157 | MP0005379_endocrine/exocrine_gland_phen | 0.66870180 |
158 | * MP0003828_pulmonary_edema | 0.66857356 |
159 | MP0002876_abnormal_thyroid_physiology | 0.66855871 |
160 | MP0005167_abnormal_blood-brain_barrier | 0.66414534 |
161 | MP0004484_altered_response_of | 0.66357146 |
162 | MP0002557_abnormal_social/conspecific_i | 0.65598565 |
163 | MP0002160_abnormal_reproductive_system | 0.64724678 |
164 | MP0008004_abnormal_stomach_pH | 0.64061360 |
165 | MP0001440_abnormal_grooming_behavior | 0.63637754 |
166 | MP0004147_increased_porphyrin_level | 0.62482396 |
167 | MP0005164_abnormal_response_to | 0.62281166 |
168 | MP0005551_abnormal_eye_electrophysiolog | 0.61315064 |
169 | MP0003755_abnormal_palate_morphology | 0.60635979 |
170 | MP0003091_abnormal_cell_migration | 0.60331898 |
171 | MP0008932_abnormal_embryonic_tissue | 0.60272566 |
172 | MP0002734_abnormal_mechanical_nocicepti | 0.59681778 |
173 | MP0005375_adipose_tissue_phenotype | 0.58339669 |
174 | MP0002572_abnormal_emotion/affect_behav | 0.57276221 |
175 | MP0002735_abnormal_chemical_nociception | 0.56861073 |
176 | * MP0005388_respiratory_system_phenotype | 0.56781460 |
177 | * MP0002133_abnormal_respiratory_system | 0.56781460 |
178 | MP0001963_abnormal_hearing_physiology | 0.56524244 |
179 | MP0002971_abnormal_brown_adipose | 0.56488961 |
180 | MP0004085_abnormal_heartbeat | 0.56176707 |
181 | MP0002282_abnormal_trachea_morphology | 0.54765687 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.22551969 |
2 | Recurrent abscess formation (HP:0002722) | 4.77234208 |
3 | Myositis (HP:0100614) | 4.61304533 |
4 | Obstructive sleep apnea (HP:0002870) | 4.58532978 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.55277705 |
6 | Abnormality of macrophages (HP:0004311) | 4.34320962 |
7 | Hematochezia (HP:0002573) | 4.34174022 |
8 | Orchitis (HP:0100796) | 4.33284402 |
9 | Concave nail (HP:0001598) | 4.07897388 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.06421029 |
11 | Optic neuritis (HP:0100653) | 4.04306093 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.04306093 |
13 | Premature rupture of membranes (HP:0001788) | 3.95654739 |
14 | Reduced antithrombin III activity (HP:0001976) | 3.76426805 |
15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76409974 |
16 | Prolonged bleeding time (HP:0003010) | 3.72852687 |
17 | Polycythemia (HP:0001901) | 3.57644284 |
18 | Abnormality of secondary sexual hair (HP:0009888) | 3.54167131 |
19 | Abnormality of the axillary hair (HP:0100134) | 3.54167131 |
20 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.52709245 |
21 | Thyroid-stimulating hormone excess (HP:0002925) | 3.52323143 |
22 | Epistaxis (HP:0000421) | 3.34438101 |
23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26920345 |
24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26920345 |
25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26920345 |
26 | Hemoptysis (HP:0002105) | 3.23539742 |
27 | Sex reversal (HP:0012245) | 3.18821161 |
28 | Abnormal sex determination (HP:0012244) | 3.18821161 |
29 | Recurrent fungal infections (HP:0002841) | 3.14167502 |
30 | Keratoconjunctivitis sicca (HP:0001097) | 3.05951688 |
31 | Mediastinal lymphadenopathy (HP:0100721) | 3.05825259 |
32 | Type I transferrin isoform profile (HP:0003642) | 3.03789102 |
33 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.98710206 |
34 | Recurrent skin infections (HP:0001581) | 2.97262857 |
35 | Conjunctival telangiectasia (HP:0000524) | 2.96235773 |
36 | Gastrointestinal infarctions (HP:0005244) | 2.95238602 |
37 | Amyloidosis (HP:0011034) | 2.94105997 |
38 | Meningitis (HP:0001287) | 2.92211204 |
39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.86579631 |
40 | Gingivitis (HP:0000230) | 2.86533874 |
41 | Chest pain (HP:0100749) | 2.86434913 |
42 | Pulmonary embolism (HP:0002204) | 2.84325095 |
43 | Congenital, generalized hypertrichosis (HP:0004540) | 2.84091053 |
44 | Keratoconjunctivitis (HP:0001096) | 2.82204105 |
45 | Esophageal varix (HP:0002040) | 2.80706568 |
46 | Congenital sensorineural hearing impairment (HP:0008527) | 2.80513777 |
47 | Increased cerebral lipofuscin (HP:0011813) | 2.79341190 |
48 | Attenuation of retinal blood vessels (HP:0007843) | 2.78201134 |
49 | Submucous cleft hard palate (HP:0000176) | 2.77281537 |
50 | Upper limb muscle weakness (HP:0003484) | 2.74779010 |
51 | Testicular atrophy (HP:0000029) | 2.72851202 |
52 | Pulmonary infiltrates (HP:0002113) | 2.72675565 |
53 | Vasculitis (HP:0002633) | 2.72122147 |
54 | Cellulitis (HP:0100658) | 2.71552188 |
55 | Increased IgE level (HP:0003212) | 2.70415346 |
56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68976697 |
57 | Obstructive lung disease (HP:0006536) | 2.68976697 |
58 | Dysostosis multiplex (HP:0000943) | 2.68125348 |
59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.67783852 |
60 | Arterial thrombosis (HP:0004420) | 2.67609440 |
61 | Seborrheic dermatitis (HP:0001051) | 2.66978361 |
62 | Gingival bleeding (HP:0000225) | 2.66829689 |
63 | Cerebral hemorrhage (HP:0001342) | 2.64472573 |
64 | Cerebral aneurysm (HP:0004944) | 2.63989307 |
65 | Abnormality of the nasal mucosa (HP:0000433) | 2.62662916 |
66 | Sleep apnea (HP:0010535) | 2.62187242 |
67 | Encephalitis (HP:0002383) | 2.59805042 |
68 | Chin dimple (HP:0010751) | 2.59399553 |
69 | Split foot (HP:0001839) | 2.57222058 |
70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56490964 |
71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56490964 |
72 | T lymphocytopenia (HP:0005403) | 2.50260832 |
73 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.48906389 |
74 | Steppage gait (HP:0003376) | 2.47061419 |
75 | Abnormal ciliary motility (HP:0012262) | 2.46340582 |
76 | Abnormality of T cell number (HP:0011839) | 2.45576450 |
77 | Urticaria (HP:0001025) | 2.42635583 |
78 | Petechiae (HP:0000967) | 2.42171626 |
79 | Purpura (HP:0000979) | 2.41164644 |
80 | Flat occiput (HP:0005469) | 2.39560338 |
81 | Hemiplegia (HP:0002301) | 2.39256645 |
82 | Leukocytosis (HP:0001974) | 2.38929151 |
83 | Sparse lateral eyebrow (HP:0005338) | 2.37298907 |
84 | Autoimmune thrombocytopenia (HP:0001973) | 2.36658971 |
85 | Peripheral hypomyelination (HP:0007182) | 2.36055069 |
86 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.34889777 |
87 | Absent/shortened dynein arms (HP:0200106) | 2.34889777 |
88 | Capillary hemangiomas (HP:0005306) | 2.34343648 |
89 | Aplasia cutis congenita (HP:0001057) | 2.33526615 |
90 | Hyperthyroidism (HP:0000836) | 2.33189623 |
91 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.32218625 |
92 | Aplasia of the phalanges of the hand (HP:0009802) | 2.32218625 |
93 | Aplasia involving bones of the extremities (HP:0009825) | 2.32218625 |
94 | Increased hepatocellular lipid droplets (HP:0006565) | 2.32028118 |
95 | Systemic lupus erythematosus (HP:0002725) | 2.31720497 |
96 | Ulnar claw (HP:0001178) | 2.29475910 |
97 | Myocardial infarction (HP:0001658) | 2.28970028 |
98 | Abnormality of dental color (HP:0011073) | 2.27901344 |
99 | Episodic fever (HP:0001954) | 2.27148301 |
100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27136529 |
101 | Osteomyelitis (HP:0002754) | 2.26197778 |
102 | Parakeratosis (HP:0001036) | 2.26171774 |
103 | Peritonitis (HP:0002586) | 2.23880047 |
104 | Abnormal platelet volume (HP:0011876) | 2.22646652 |
105 | Overfolded helix (HP:0000396) | 2.22399126 |
106 | Vertigo (HP:0002321) | 2.20995700 |
107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19754247 |
108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19754247 |
109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19754247 |
110 | Reticulocytopenia (HP:0001896) | 2.19387128 |
111 | Stomatitis (HP:0010280) | 2.19342339 |
112 | Mitral regurgitation (HP:0001653) | 2.18261913 |
113 | Impaired platelet aggregation (HP:0003540) | 2.18115435 |
114 | Abnormal platelet function (HP:0011869) | 2.18115435 |
115 | Abnormal pupillary function (HP:0007686) | 2.16897416 |
116 | Nonprogressive disorder (HP:0003680) | 2.16356768 |
117 | Sensory axonal neuropathy (HP:0003390) | 2.16266636 |
118 | Mucosal telangiectasiae (HP:0100579) | 2.16064456 |
119 | Hemorrhage of the eye (HP:0011885) | 2.15435342 |
120 | Inflammation of the large intestine (HP:0002037) | 2.15157603 |
121 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.15097771 |
122 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.15097771 |
123 | Portal hypertension (HP:0001409) | 2.14416798 |
124 | Tracheomalacia (HP:0002779) | 2.13952985 |
125 | Recurrent viral infections (HP:0004429) | 2.13479544 |
126 | Mucopolysacchariduria (HP:0008155) | 2.13412278 |
127 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13412278 |
128 | Difficulty running (HP:0009046) | 2.12435633 |
129 | Vacuolated lymphocytes (HP:0001922) | 2.12200080 |
130 | Abnormality of the peritoneum (HP:0002585) | 2.11968245 |
131 | Abnormality of magnesium homeostasis (HP:0004921) | 2.11567426 |
132 | Distal lower limb amyotrophy (HP:0008944) | 2.10982725 |
133 | Thrombophlebitis (HP:0004418) | 2.10906407 |
134 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.10414138 |
135 | Atelectasis (HP:0100750) | 2.10293455 |
136 | Exertional dyspnea (HP:0002875) | 2.10055386 |
137 | Microcytic anemia (HP:0001935) | 2.08359455 |
138 | Nasolacrimal duct obstruction (HP:0000579) | 2.07217581 |
139 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06976053 |
140 | Focal motor seizures (HP:0011153) | 2.06526419 |
141 | Abnormality of the pleura (HP:0002103) | 2.06434826 |
142 | Muscle fiber splitting (HP:0003555) | 2.05305174 |
143 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05062079 |
144 | Spontaneous hematomas (HP:0007420) | 2.03292965 |
145 | Hypoparathyroidism (HP:0000829) | 2.02727443 |
146 | Loss of speech (HP:0002371) | 2.02327560 |
147 | Optic disc pallor (HP:0000543) | 2.01619598 |
148 | Gastrointestinal inflammation (HP:0004386) | 2.01487529 |
149 | Interstitial pulmonary disease (HP:0006530) | 2.01087866 |
150 | Pulmonary artery stenosis (HP:0004415) | 1.99797131 |
151 | Macrocytic anemia (HP:0001972) | 1.98894434 |
152 | Hypophosphatemic rickets (HP:0004912) | 1.98078953 |
153 | Renal Fanconi syndrome (HP:0001994) | 1.97996686 |
154 | Increased CSF protein (HP:0002922) | 1.96867423 |
155 | Colitis (HP:0002583) | 1.95533917 |
156 | Supernumerary spleens (HP:0009799) | 1.93813695 |
157 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.93039999 |
158 | Joint hemorrhage (HP:0005261) | 1.92740278 |
159 | Abnormality of T cells (HP:0002843) | 1.92718240 |
160 | Severe visual impairment (HP:0001141) | 1.92020549 |
161 | Abnormality of the hepatic vasculature (HP:0006707) | 1.90954898 |
162 | Venous insufficiency (HP:0005293) | 1.90929786 |
163 | Asymmetric septal hypertrophy (HP:0001670) | 1.90618134 |
164 | Granulocytopenia (HP:0001913) | 1.89843424 |
165 | Cerebral ischemia (HP:0002637) | 1.89660397 |
166 | Abnormal hemoglobin (HP:0011902) | 1.89430059 |
167 | Hypertensive crisis (HP:0100735) | 1.89150722 |
168 | Prolonged partial thromboplastin time (HP:0003645) | 1.89065205 |
169 | Absent speech (HP:0001344) | 1.88205662 |
170 | Progressive external ophthalmoplegia (HP:0000590) | 1.88127758 |
171 | Porencephaly (HP:0002132) | 1.87931837 |
172 | Ocular albinism (HP:0001107) | 1.87648661 |
173 | Abnormal large intestine physiology (HP:0012700) | 1.85509119 |
174 | Abnormality of the columella (HP:0009929) | 1.84714655 |
175 | Abnormally folded helix (HP:0008544) | 1.84591498 |
176 | Morphological abnormality of the middle ear (HP:0008609) | 1.84226975 |
177 | Abnormal glycosylation (HP:0012345) | 1.83722613 |
178 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83722613 |
179 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83722613 |
180 | Abnormal protein glycosylation (HP:0012346) | 1.83722613 |
181 | Synostosis involving the elbow (HP:0003938) | 1.82765337 |
182 | Humeroradial synostosis (HP:0003041) | 1.82765337 |
183 | Bowel incontinence (HP:0002607) | 1.81542599 |
184 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81151340 |
185 | Abnormality of the tricuspid valve (HP:0001702) | 1.80843310 |
186 | Annular pancreas (HP:0001734) | 1.80037633 |
187 | Hypothermia (HP:0002045) | 1.78468226 |
188 | Hypomagnesemia (HP:0002917) | 1.78179949 |
189 | Menorrhagia (HP:0000132) | 1.77223553 |
190 | Microvesicular hepatic steatosis (HP:0001414) | 1.76235595 |
191 | Venous abnormality (HP:0002624) | 1.72964379 |
192 | Bradycardia (HP:0001662) | 1.71473445 |
193 | Lipid accumulation in hepatocytes (HP:0006561) | 1.70721008 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MKNK2 | 5.67131251 |
2 | CASK | 5.27721935 |
3 | TNIK | 5.22084907 |
4 | TLK1 | 3.98054229 |
5 | TIE1 | 3.11563498 |
6 | EIF2AK3 | 3.10822640 |
7 | BLK | 3.10041259 |
8 | MKNK1 | 3.09462170 |
9 | MAP4K1 | 2.67929473 |
10 | MAP2K3 | 2.49216736 |
11 | NLK | 2.24088069 |
12 | TYK2 | 2.09840910 |
13 | * CSK | 2.02679334 |
14 | ERN1 | 1.97615325 |
15 | STK16 | 1.95174293 |
16 | ZAP70 | 1.92646094 |
17 | DMPK | 1.88349092 |
18 | PRPF4B | 1.87900480 |
19 | JAK3 | 1.73276769 |
20 | EIF2AK2 | 1.68161048 |
21 | STK39 | 1.60974263 |
22 | BTK | 1.56418644 |
23 | KDR | 1.54950217 |
24 | MAP3K3 | 1.52515844 |
25 | MAP3K14 | 1.50090453 |
26 | MAP3K11 | 1.47455511 |
27 | CLK1 | 1.41442163 |
28 | IRAK1 | 1.38486775 |
29 | SYK | 1.36352680 |
30 | MAP3K13 | 1.33537004 |
31 | ITK | 1.29263410 |
32 | * HCK | 1.28923749 |
33 | KIT | 1.28067695 |
34 | GRK6 | 1.26766094 |
35 | MUSK | 1.26440612 |
36 | TEC | 1.25235045 |
37 | TXK | 1.24302739 |
38 | IRAK4 | 1.24255922 |
39 | NME2 | 1.22113973 |
40 | TNK2 | 1.16981293 |
41 | PRKD2 | 1.15115712 |
42 | CAMK1 | 1.15064698 |
43 | JAK1 | 1.13002978 |
44 | TBK1 | 1.12166308 |
45 | IRAK3 | 1.12128845 |
46 | FGR | 1.11809660 |
47 | PKN1 | 1.10391365 |
48 | MAP2K7 | 1.09411429 |
49 | CAMKK2 | 1.06465664 |
50 | TAOK3 | 1.05978435 |
51 | MATK | 1.05340866 |
52 | SRPK1 | 1.04486931 |
53 | PRKAA2 | 1.01033126 |
54 | CAMK2B | 1.01000728 |
55 | CSF1R | 1.00575732 |
56 | * LYN | 1.00261868 |
57 | PNCK | 1.00015102 |
58 | MAPK15 | 0.99927734 |
59 | GRK1 | 0.99468121 |
60 | YES1 | 0.98401993 |
61 | JAK2 | 0.97647067 |
62 | IKBKE | 0.96601000 |
63 | TAOK1 | 0.96477132 |
64 | CDK19 | 0.95428067 |
65 | TGFBR2 | 0.91759293 |
66 | OXSR1 | 0.91754063 |
67 | EIF2AK1 | 0.89890072 |
68 | MAPK13 | 0.89801207 |
69 | PIK3CG | 0.89199175 |
70 | IRAK2 | 0.86804071 |
71 | CDK9 | 0.85172957 |
72 | TGFBR1 | 0.84017025 |
73 | PIM2 | 0.82018283 |
74 | GRK7 | 0.81081867 |
75 | UHMK1 | 0.81009452 |
76 | PTK2B | 0.75648703 |
77 | NTRK3 | 0.75272280 |
78 | STK10 | 0.73974875 |
79 | RIPK1 | 0.72179746 |
80 | NUAK1 | 0.70915348 |
81 | PHKG1 | 0.69349526 |
82 | PHKG2 | 0.69349526 |
83 | CAMK2D | 0.67792026 |
84 | STK11 | 0.67219972 |
85 | MAPK7 | 0.67142687 |
86 | BMPR1B | 0.67054164 |
87 | KSR2 | 0.66530320 |
88 | PDPK1 | 0.66334048 |
89 | MARK2 | 0.65783035 |
90 | PDK1 | 0.65359304 |
91 | MAPK4 | 0.64209437 |
92 | PTK6 | 0.63873832 |
93 | HIPK2 | 0.63451730 |
94 | PRKG2 | 0.63399735 |
95 | CAMK2A | 0.63073179 |
96 | TRPM7 | 0.62661688 |
97 | MAPKAPK5 | 0.61521670 |
98 | IKBKB | 0.61471447 |
99 | TTN | 0.61392647 |
100 | DYRK1A | 0.61134817 |
101 | MOS | 0.59281429 |
102 | BMPR2 | 0.58432011 |
103 | ADRBK1 | 0.58346530 |
104 | MAP3K6 | 0.58022102 |
105 | FGFR3 | 0.57644091 |
106 | * FES | 0.55539577 |
107 | EPHA3 | 0.55432412 |
108 | EPHB2 | 0.55196870 |
109 | BUB1 | 0.54684205 |
110 | MAP3K7 | 0.54578951 |
111 | MINK1 | 0.53502358 |
112 | CDC42BPA | 0.52293785 |
113 | PAK2 | 0.52186769 |
114 | LRRK2 | 0.51954011 |
115 | INSRR | 0.50682270 |
116 | ADRBK2 | 0.49206367 |
117 | MARK3 | 0.48722977 |
118 | TAOK2 | 0.47868051 |
119 | PRKG1 | 0.47041665 |
120 | WNK4 | 0.46675175 |
121 | SGK3 | 0.46230806 |
122 | FGFR4 | 0.45658832 |
123 | PDGFRB | 0.44511134 |
124 | RPS6KA5 | 0.42569932 |
125 | * FYN | 0.42527498 |
126 | WNK1 | 0.41187046 |
127 | CDK8 | 0.41154178 |
128 | CSNK1G1 | 0.40987461 |
129 | DAPK3 | 0.40755005 |
130 | SGK2 | 0.40012924 |
131 | EGFR | 0.38572043 |
132 | ROCK2 | 0.37899071 |
133 | PRKD1 | 0.37661311 |
134 | CDK3 | 0.37442244 |
135 | MAPK12 | 0.37309430 |
136 | PRKCE | 0.37024327 |
137 | EPHB1 | 0.36849670 |
138 | RPS6KA2 | 0.36828603 |
139 | IGF1R | 0.36796807 |
140 | GRK5 | 0.35376324 |
141 | SIK3 | 0.34895434 |
142 | RIPK4 | 0.33520490 |
143 | ACVR1B | 0.33425239 |
144 | PRKCQ | 0.33288678 |
145 | TRIB3 | 0.33286991 |
146 | RET | 0.32967337 |
147 | CDK7 | 0.31387492 |
148 | * LCK | 0.31282579 |
149 | RPS6KC1 | 0.30949963 |
150 | RPS6KL1 | 0.30949963 |
151 | DYRK2 | 0.30536574 |
152 | CSNK1A1L | 0.30073116 |
153 | SIK2 | 0.29535657 |
154 | DAPK2 | 0.29354206 |
155 | MAP3K2 | 0.28641167 |
156 | MAP3K1 | 0.28578198 |
157 | VRK1 | 0.28343205 |
158 | MAPKAPK3 | 0.27691155 |
159 | CAMK4 | 0.27516321 |
160 | EPHA4 | 0.27466025 |
161 | NEK9 | 0.26520880 |
162 | TESK2 | 0.26512139 |
163 | CAMK2G | 0.26253537 |
164 | PRKACA | 0.26191742 |
165 | CDK14 | 0.24570249 |
166 | CSNK2A2 | 0.24453942 |
167 | ABL1 | 0.24442102 |
168 | NME1 | 0.24311215 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.23041439 |
2 | Protein export_Homo sapiens_hsa03060 | 2.86436441 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74017286 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69846862 |
5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.27226507 |
6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.17507952 |
7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.17349896 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.15772130 |
9 | Long-term depression_Homo sapiens_hsa04730 | 2.12470209 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12127484 |
11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.11097859 |
12 | Phototransduction_Homo sapiens_hsa04744 | 2.10524888 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00055399 |
14 | Tuberculosis_Homo sapiens_hsa05152 | 1.90001283 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.88806822 |
16 | Axon guidance_Homo sapiens_hsa04360 | 1.84451816 |
17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.80154180 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78759654 |
19 | * Malaria_Homo sapiens_hsa05144 | 1.73448656 |
20 | Homologous recombination_Homo sapiens_hsa03440 | 1.72457113 |
21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71301885 |
22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.66820658 |
23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63586298 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63151342 |
25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.57576333 |
26 | Asthma_Homo sapiens_hsa05310 | 1.56883524 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54271774 |
28 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.52806164 |
29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48973038 |
30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48483583 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44822218 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44112755 |
33 | Morphine addiction_Homo sapiens_hsa05032 | 1.42683036 |
34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.42476566 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42304741 |
36 | Taste transduction_Homo sapiens_hsa04742 | 1.40200460 |
37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39310462 |
38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38177124 |
39 | Phagosome_Homo sapiens_hsa04145 | 1.37657460 |
40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.35203599 |
41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35139543 |
42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.34608832 |
43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33878224 |
44 | Pertussis_Homo sapiens_hsa05133 | 1.32072409 |
45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31623181 |
46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31011203 |
47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30925504 |
48 | Lysosome_Homo sapiens_hsa04142 | 1.27247775 |
49 | Measles_Homo sapiens_hsa05162 | 1.25668316 |
50 | Influenza A_Homo sapiens_hsa05164 | 1.22553199 |
51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.21867424 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21515580 |
53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21300258 |
54 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20322822 |
55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.19489826 |
56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19471332 |
57 | Legionellosis_Homo sapiens_hsa05134 | 1.16880190 |
58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14072394 |
59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12724598 |
60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12019336 |
61 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.11040574 |
62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11000334 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07889574 |
64 | Renin secretion_Homo sapiens_hsa04924 | 1.06109399 |
65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03796258 |
66 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.02759731 |
67 | Amoebiasis_Homo sapiens_hsa05146 | 1.02621591 |
68 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02126226 |
69 | Basal transcription factors_Homo sapiens_hsa03022 | 1.00696163 |
70 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00017651 |
71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97550087 |
72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97301420 |
73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97215982 |
74 | Salmonella infection_Homo sapiens_hsa05132 | 0.94789131 |
75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.93436080 |
76 | Melanogenesis_Homo sapiens_hsa04916 | 0.92368116 |
77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92318385 |
78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91376924 |
79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.90913803 |
80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90578790 |
81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90541569 |
82 | Hepatitis B_Homo sapiens_hsa05161 | 0.88966970 |
83 | Melanoma_Homo sapiens_hsa05218 | 0.88604210 |
84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87935990 |
85 | Shigellosis_Homo sapiens_hsa05131 | 0.87624777 |
86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86542472 |
87 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85480383 |
88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85102735 |
89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84082753 |
90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83686525 |
91 | Salivary secretion_Homo sapiens_hsa04970 | 0.83481855 |
92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82684925 |
93 | Gap junction_Homo sapiens_hsa04540 | 0.81854090 |
94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81643773 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.81507894 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81431489 |
97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81335941 |
98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81207474 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81058566 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79937604 |
101 | Endocytosis_Homo sapiens_hsa04144 | 0.79338418 |
102 | Apoptosis_Homo sapiens_hsa04210 | 0.78373055 |
103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76819526 |
104 | Platelet activation_Homo sapiens_hsa04611 | 0.75946327 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75935185 |
106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74345338 |
107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74331487 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73983633 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73595147 |
110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73364204 |
111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73097530 |
112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72626098 |
113 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.70634213 |
114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70579863 |
115 | DNA replication_Homo sapiens_hsa03030 | 0.70198489 |
116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69271700 |
117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66590614 |
118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66178842 |
119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66075796 |
120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65659342 |
121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64965033 |
122 | Focal adhesion_Homo sapiens_hsa04510 | 0.64778543 |
123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64383082 |
124 | RNA polymerase_Homo sapiens_hsa03020 | 0.64206815 |
125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63223185 |
126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62242211 |
127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62225304 |
128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62035400 |
129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61688727 |
130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60931816 |
131 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60555979 |
132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58876817 |
133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58167748 |
134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57752153 |
135 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57672175 |
136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57588626 |
137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57549789 |
138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56499607 |
139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56010369 |
140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54596448 |
141 | Insulin resistance_Homo sapiens_hsa04931 | 0.54162171 |
142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53722437 |
143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52364952 |
144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52107760 |
145 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51850993 |
146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50954251 |
147 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50372552 |
148 | Prostate cancer_Homo sapiens_hsa05215 | 0.49256801 |
149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49128769 |
150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48987042 |
151 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48521599 |
152 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48398332 |
153 | Tight junction_Homo sapiens_hsa04530 | 0.47304187 |
154 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47141096 |
155 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47048225 |
156 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46885341 |
157 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45778206 |
158 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45741913 |
159 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43699294 |
160 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43676895 |
161 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41878315 |
162 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41842247 |
163 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41640063 |
164 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41474230 |
165 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41182570 |
166 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40954999 |
167 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39263640 |
168 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39114358 |
169 | Adherens junction_Homo sapiens_hsa04520 | 0.36914802 |